https://www.selleckchem.com/pr....oducts/gusacitinib.h
The pooled analysis of studies revealed an overall post-ERCP bleeding rate of 5.7% (95% confidence interval 3-10.6) on sustained DAPT. Post-ERCP bleeding in DAPT Cohort was not significantly higher as compared with aspirin only Cohort (odds ratio 1.14, 95% confidence interval 0.46-2.81). The immediate bleeding and delayed bleeding rates cannot be generalized due to low number of studies. The first systematic review and meta-analysis showed that post-ERCP bleeding rates are not significantly higher in DAPT cohort as compared with asp